daunorubicin has been researched along with losartan potassium in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollum, FJ; Hutton, JJ; Roodman, GD | 1 |
| Kaku, M; Motomura, S; Nakamura, K; Okano, H | 1 |
| Caro, J; Erslev, AJ; Piroso, E | 1 |
| Blackett, NM; Millar, JL | 1 |
| Essers, U; Mann, H | 1 |
| Jelkmann, W; Wolff, M | 1 |
| Eriksson, M; Hast, R; Jakovleva, K | 1 |
| Bourgeade, MF; Carvalho, G; Chapel, A; Charpentier, B; Cherbonnier, C; Hirsch, F; Kroemer, G; Lefaucheur, C; Métivier, D; Pallardy, M | 1 |
| Benchimol, S; Kazakova, L; Ma, W; Miller, D; Pham, TD | 1 |
9 other study(ies) available for daunorubicin and losartan potassium
| Article | Year |
|---|---|
DNA polymerase activities during erythropoiesis. Effects of erythropietin, vinblastine, colcemid, and daunomycin.
Topics: Animals; Atmospheric Pressure; Centrifugation, Density Gradient; Daunorubicin; Demecolcine; Depression, Chemical; DNA; DNA Nucleotidyltransferases; Erythropoiesis; Erythropoietin; Female; Heme; Iron Radioisotopes; Mice; Spleen; Stimulation, Chemical; Thymidine; Time Factors; Tritium; Vinblastine | 1975 |
In vitro differentiation of a human erythroid cell line (KMOE) induced by some metabolic inhibitors.
Topics: Antimetabolites; Benzidines; Cell Differentiation; Cell Line; Cytarabine; Daunorubicin; Erythrocytes; Erythropoietin; Hemoglobins; Humans; Isoelectric Focusing; Mitomycin; Mitomycins; Radioimmunoassay; Staining and Labeling | 1985 |
Inappropriate increase in erythropoietin titers during chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythropoietin; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1989 |
The effect of various cytotoxic agents on the erythroid precursors in rat bone marrow.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Bone Marrow; Bone Marrow Cells; Busulfan; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Erythrocytes; Erythropoiesis; Erythropoietin; Iron Radioisotopes; Methotrexate; Nitrogen Mustard Compounds; Radiation Effects; Rats | 1974 |
[Erythropoietin activity of blood in anemia with hypoplastic and hyperplastic bone marrow].
Topics: Adult; Aged; Anemia; Anemia, Aplastic; Anemia, Hypochromic; Anemia, Macrocytic; Animals; Bone Marrow; Bone Marrow Diseases; Daunorubicin; Erythropoietin; Female; Hemoglobins; Humans; Male; Middle Aged; Phenylhydrazines; Rabbits; Radiation Effects | 1971 |
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.
Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Erythropoietin; Humans; Ifosfamide; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver Neoplasms, Experimental; Methotrexate; Organoplatinum Compounds; Tetrazolium Salts; Tumor Cells, Cultured; Vincristine | 1993 |
Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Daunorubicin; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Myelodysplastic Syndromes; Remission Induction; Thioguanine | 1998 |
Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Daunorubicin; Erythropoietin; Humans; Janus Kinase 2; Kidney Neoplasms; NF-kappa B; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Erythropoietin; Signal Transduction; U937 Cells; Vinblastine | 2005 |
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p27; Daunorubicin; DNA Damage; Doxorubicin; Erythropoietin; Humans; Leukemia; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2019 |